HIT Consultant June 12, 2024
Fred Pennic

What You Should Know:

Foresite Capital, a San Francisco, CA-based healthcare and life sciences investment firm, announced today the successful closing of its sixth fund with a significant $900M in capital commitments. This new fund fuels Foresite’s mission to invest in groundbreaking technologies across the healthcare spectrum.

– Fund VI attracted a diverse group of limited partners, including university endowments, charitable foundations, medical institutions, pension funds, insurance companies, private banks, and family offices from around the world.

Investing in the Future of Healthcare

Foresite Capital has a proven track record of backing innovative companies with a data-driven approach. With over $3.5 billion under management, they have supported numerous companies through IPOs, mergers and acquisitions, and successful drug approvals...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma / Biotech, Precision Medicine, Trends
Uses of precision medicine in healthcare
Helix and Recursion to Leverage Clinico-Genomics for Drug Discovery
9 Requirements for an Optimal Genetic Test Benefit Program
Innovations in Preventive Care – Staying Ahead of Health Issues
UK Biobank Pivoting to Platform-Only Model For Big Data Sharing

Share This Article